Alexander Craig Fanaroff, MD, MHS
Assistant Professor of Medicine (Cardiovascular Medicine) at the Hospital of the University of Pennsylvania
Attending, Hospital of the University of Pennsylvania
Faculty member, Cardiovascular Outcomes, Quality, and Evaluative Research Center
Senior Fellow, Leonard Davis Institute for Health Economics
Affiliated Faculty, Penn Institute for Translational Medicine and Therapeutics, Philadelphia, Pennsylvania
Affiliated Faculty, Center for Health Incentives and Behavioral Economics/Penn Roybal Center
Affiliated Faculty, Penn Palliative and Advanced Illness Research Center
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
11-103 South PCAM
Philadelphia, PA 19104
11-103 South PCAM
Philadelphia, PA 19104
Office: 215-615-7674
Education:
AB (English)
Duke University, 2007.
MD (Medicine)
Duke University School of Medicine, 2011.
MHS (Clinical Research)
Duke University School of Medicine, 2018.
Permanent linkAB (English)
Duke University, 2007.
MD (Medicine)
Duke University School of Medicine, 2011.
MHS (Clinical Research)
Duke University School of Medicine, 2018.
Selected Publications
Nathan AS, Reddy KP, Eberly LA, Fanaroff AC, Julien HM, Fiorilli PW, Wald J, Cevasco M, Bermudez C, Basir MB, Kapur N, Roswell R, Groeneveld PW, Giri J.: Racial, Ethnic, Socioeconomic, and Geographic Inequities in Access to Mechanical Circulatory Support. J Soc Cardiovasc Angiogr Interv. 3: 101193, 2024.Patel PP, Fanaroff AC: Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy. Med Clin North Am 2024.
Fanaroff AC, Lopes RD, Alexander JH: Antithrombotic therapy in patients with atrial fibrillation and recent coronary stenting, with or without an acute coronary syndrome. The ESC Textbook of Thrombosis. De Caterina R, Moliterno DJ, Kristensen SD (eds.). Oxford University Press, 2024.
Fanaroff AC, Hirshfeld Jr JW: Chronic Coronary Disease. Med Clin North Am 2024.
Fanaroff AC, Sun LL.: High-Sensitivity Troponin in Patients With Cancer: Sensitive But Not Specific. JACC CardioOncol 5: 610-612, Oct 2023.
Reddy KP, Faggioni M, Eberly LA, Halaby R, Sanghavi M, Lewey J, Mehran R, Coylewright M, Herrmann HC, Giri J, Fanaroff AC, Nathan AS.: Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review. JAMA Cardiol 8: 871-878, Sep 2023.
Fanaroff AC, Faggioni M.: Managing Myocardial Infarction in the Age of Multimorbidity. J Am Coll Cardiol 82: 982-984, Sep 2023.
Reddy KP, Eberly LA, Halaby R, Julien H, Khatana SAM, Dayoub EJ, Coylewright M, Alkhouli M, Fiorilli PN, Kobayashi TJ, Goldberg DM, Santangeli P, Herrmann HC, Giri J, Groeneveld PW, Fanaroff AC, Nathan AS.: Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion. J Am Heart Assoc 12: e028032, Mar 2023.
Nathan AS, Reddy KP, Yang L, Eberly LA, Dayoub EJ, Khatana SAM, Julien HM, Desai ND, Szeto WY, Herrmann HC, Kobayashi TJ, Fiorilli P, Batchelor WB, Mehran R, Alkhouli MA, Giri J, Groeneveld PW, Fanaroff AC.: Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies. JAMA Cardiol 8: 120-128, Feb 2023.
Fanaroff AC, Lopes RD.: COVID-19 Thrombotic Complications and Therapeutic Strategies. Annu Rev Med. (eds.). 74: 15-30, Jan 27 2023.